Variant report

Variant	nsv881030
Chromosome Location	chr4:189139613-189310768
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:189203531-189203904	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:189308557-189308573	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL3	chr4:189246967-189247207	GM12878	blood:	n/a	n/a
4	BCL3	chr4:189247008-189247247	GM12878	blood:	n/a	n/a
5	BHLHE40	chr4:189291962-189292207	GM12878	blood:	n/a	n/a
6	BHLHE40	chr4:189167743-189167747	K562	blood:	n/a	n/a
7	CBX3	chr4:189304915-189305326	HCT-116	colon:	n/a	n/a
8	CEBPB	chr4:189250133-189250458	HepG2	liver:	n/a	n/a
9	CEBPB	chr4:189262870-189263143	A549	lung:	n/a	chr4:189263022-189263033
10	CEBPB	chr4:189178682-189178864	IMR90	lung:	n/a	n/a
11	CEBPB	chr4:189220329-189220641	IMR90	lung:	n/a	n/a
12	CEBPB	chr4:189183664-189184084	IMR90	lung:	n/a	n/a
13	CEBPB	chr4:189183712-189184079	A549	lung:	n/a	n/a
14	CEBPB	chr4:189196510-189196762	HepG2	liver:	n/a	chr4:189196648-189196659
15	CEBPB	chr4:189262860-189263130	K562	blood:	n/a	chr4:189263022-189263033
16	CEBPB	chr4:189288202-189288489	IMR90	lung:	n/a	chr4:189288365-189288376
17	CEBPB	chr4:189216845-189217381	IMR90	lung:	n/a	chr4:189216947-189216964 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189216949-189216960 chr4:189217185-189217198
18	CEBPB	chr4:189216851-189217267	HepG2	liver:	n/a	chr4:189216947-189216964 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189216949-189216960 chr4:189217185-189217198
19	CEBPB	chr4:189216927-189217305	K562	blood:	n/a	chr4:189216947-189216964 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189216949-189216960 chr4:189217185-189217198
20	CEBPB	chr4:189203810-189204281	H1-hESC	embryonic stem cell:	n/a	chr4:189204116-189204129
21	CEBPB	chr4:189183741-189184058	A549	lung:	n/a	n/a
22	CEBPB	chr4:189288199-189288526	HepG2	liver:	n/a	chr4:189288365-189288376
23	CEBPB	chr4:189254888-189255129	IMR90	lung:	n/a	n/a
24	CEBPB	chr4:189262873-189263190	IMR90	lung:	n/a	chr4:189263022-189263033
25	CEBPB	chr4:189183666-189184101	A549	lung:	n/a	n/a
26	CEBPB	chr4:189262856-189263109	H1-hESC	embryonic stem cell:	n/a	chr4:189263022-189263033
27	CEBPB	chr4:189216908-189217275	A549	lung:	n/a	chr4:189216947-189216964 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189217187-189217198 chr4:189217185-189217198 chr4:189216949-189216960 chr4:189217185-189217198
28	CEBPB	chr4:189196563-189196804	A549	lung:	n/a	chr4:189196648-189196659
29	CEBPB	chr4:189183611-189184091	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr4:189142068-189142182	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr4:189262859-189263200	HepG2	liver:	n/a	chr4:189263022-189263033
32	CHD2	chr4:189183652-189184023	Hela-S3	cervix:	n/a	n/a
33	CHD2	chr4:189203695-189203923	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD2	chr4:189148012-189148027	H1-hESC	embryonic stem cell:	n/a	n/a
35	CHD2	chr4:189204241-189204442	H1-hESC	embryonic stem cell:	n/a	chr4:189204291-189204301
36	CTBP2	chr4:189203621-189204419	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr4:189294026-189294421	T-47D	breast:	n/a	n/a
38	CTCF	chr4:189294180-189294330	BE2_C	brain:	n/a	n/a
39	CTCF	chr4:189167780-189167930	BJ	skin:	n/a	n/a
40	CTCF	chr4:189294263-189294322	Medullo	brain:	n/a	n/a
41	CTCF	chr4:189294110-189294389	Lung_OC	lung:	n/a	n/a
42	CTCF	chr4:189189810-189189930	A549	lung:	n/a	chr4:189189848-189189866 chr4:189189850-189189863 chr4:189189843-189189864
43	CTCF	chr4:189181221-189181266	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTCF	chr4:189294168-189294337	NHEK	skin:	n/a	n/a
45	CTCF	chr4:189294127-189294366	HepG2	liver:	n/a	n/a
46	CTCF	chr4:189167720-189167870	HEEpiC	esophagus:	n/a	n/a
47	CTCF	chr4:189167577-189168053	A549	lung:	n/a	n/a
48	CTCF	chr4:189294120-189294270	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr4:189294094-189294396	A549	lung:	n/a	n/a
50	CTCF	chr4:189294007-189294389	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:189258348-189258398	SK-N-SH	brain:	n/a
2	chr4:189258348-189258398	SK-N-SH	brain:	n/a
3	chr4:189254654-189254704	PFSK-1	brain:	n/a
4	chr4:189204473-189204523	MCF-7	breast:	n/a
5	chr4:189203391-189203441	PrEC	prostate:	n/a
6	chr4:189258068-189258118	AG10803	skin:	n/a
7	chr4:189158066-189158116	GM12878	blood:	n/a
8	chr4:189200528-189200578	ECC-1	luminal epithelium:	n/a
9	chr4:189200528-189200578	NHDF-neo	bronchial:	n/a
10	chr4:189254654-189254704	BJ	skin:	n/a
11	chr4:189254654-189254704	HNPCEpiC	eye:	n/a
12	chr4:189254654-189254704	BE2_C	brain:	n/a
13	chr4:189191704-189191754	Jurkat	blood:	n/a
14	chr4:189258068-189258118	HNPCEpiC	eye:	n/a
15	chr4:189158087-189158137	Hepatocyte	liver:	n/a
16	chr4:189203391-189203441	SK-N-SH_RA	brain:	n/a
17	chr4:189204589-189204639	RPTEC	kidney:	n/a
18	chr4:189158087-189158137	SK-N-MC	brain:	n/a
19	chr4:189191535-189191585	NHDF-neo	bronchial:	n/a
20	chr4:189258068-189258118	SK-N-MC	brain:	n/a
21	chr4:189258348-189258398	LNCaP	prostate:	n/a
22	chr4:189191704-189191754	HCPEpiC	choroid plexus:	n/a
23	chr4:189204589-189204639	H1-hESC	embryonic stem cell:	embryo
24	chr4:189254654-189254704	HEEpiC	esophagus:	n/a
25	chr4:189203762-189203812	HL-60	blood:	n/a
26	chr4:189203391-189203441	HMEC	breast:	n/a
27	chr4:189158022-189158072	HCPEpiC	choroid plexus:	n/a
28	chr4:189206559-189206609	AG09319	gingival:	n/a
29	chr4:189258068-189258118	LNCaP	prostate:	n/a
30	chr4:189258195-189258245	HCPEpiC	choroid plexus:	n/a
31	chr4:189258195-189258245	HEK293	kidney:	embryo
32	chr4:189254654-189254704	ProgFib	skin:	n/a
33	chr4:189203965-189204015	GM19239	blood:	n/a
34	chr4:189220624-189220674	SK-N-SH_RA	brain:	n/a
35	chr4:189203391-189203441	HAEpiC	amniotic membrane:	n/a
36	chr4:189206559-189206609	HIPEpiC	eye:	n/a
37	chr4:189203762-189203812	HCT-116	colon:	n/a
38	chr4:189203965-189204015	GM12891	blood:	n/a
39	chr4:189254654-189254704	HL-60	blood:	n/a
40	chr4:189203391-189203441	Hepatocyte	liver:	n/a
41	chr4:189203965-189204015	H1-hESC	embryonic stem cell:	embryo
42	chr4:189258068-189258118	BE2_C	brain:	n/a
43	chr4:189204473-189204523	A549	lung:	n/a
44	chr4:189203762-189203812	HRCEpiC	kidney:	n/a
45	chr4:189139691-189139741	PANC-1	pancreas:	n/a
46	chr4:189203962-189204012	HCM	heart:	n/a
47	chr4:189139691-189139741	PFSK-1	brain:	n/a
48	chr4:189139691-189139741	HAEpiC	amniotic membrane:	n/a
49	chr4:189258348-189258398	HNPCEpiC	eye:	n/a
50	chr4:189203965-189204015	AG04449	skin:	fetal

No.	Distal block	Cell Line	Cell type
1	chr4:188914697..188915636-chr4:189293778..189294511,3	MCF-7	breast:
2	chr4:188587219..188588049-chr4:189293834..189294448,2	MCF-7	breast:
3	chr20:30047555..30048272-chr4:189297803..189298552,2	MCF-7	breast:
4	chr4:188914670..188915671-chr4:189167438..189168869,4	MCF-7	breast:
5	chr4:188527128..188528286-chr4:189293970..189294660,4	MCF-7	breast:
6	chr4:188914709..188915626-chr4:189293756..189294718,5	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TRIML2-8	chr4:189222763-189222834	NONHSAT099739
2	lnc-TRIML2-8	chr4:189219369-189219538	NONHSAT099739

Variant related genes	Relation type
ENSG00000242169	TF binding region
ENSG00000242169	CpG island

Extended variants
information (count: 5447 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:5447 , 50 per page) page: 1 2 3 4 5 6 7 ... 109

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7682583	chr4:189139613-189139614	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs559207123	chr4:189139628-189139629	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs553259688	chr4:189139648-189139649	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs572741135	chr4:189139699-189139700	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs545070048	chr4:189139700-189139701	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs28385898	chr4:189139722-189139723	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs7661016	chr4:189139730-189139731	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs574950611	chr4:189139746-189139747	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs189585837	chr4:189139770-189139771	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs181121363	chr4:189139786-189139787	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs529521782	chr4:189139789-189139790	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs542938880	chr4:189139797-189139798	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs375618183	chr4:189139799-189139800	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs528461774	chr4:189139817-189139818	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs551313626	chr4:189139845-189139846	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs186257568	chr4:189139846-189139847	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs4441822	chr4:189139854-189139855	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs551075232	chr4:189139860-189139861	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs564106387	chr4:189139879-189139880	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs573129672	chr4:189139889-189139890	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs567327246	chr4:189139890-189139891	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs190618343	chr4:189139911-189139912	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs546575172	chr4:189139929-189139930	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs116060414	chr4:189140026-189140027	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs538945369	chr4:189140044-189140045	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs558556054	chr4:189140084-189140085	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs575335727	chr4:189140095-189140096	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs183500013	chr4:189140107-189140108	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs554685547	chr4:189140109-189140110	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs574140544	chr4:189140122-189140123	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs543250055	chr4:189140137-189140138	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs376844096	chr4:189140173-189140174	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs149789593	chr4:189140251-189140252	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs559694028	chr4:189140263-189140264	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs563417137	chr4:189140264-189140265	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs187130203	chr4:189140270-189140271	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs192148739	chr4:189140278-189140279	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs182642443	chr4:189140279-189140280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs540175332	chr4:189140280-189140281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs530841161	chr4:189140283-189140284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs71642077	chr4:189140286-189140287	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs147939481	chr4:189140287-189140288	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs4241900	chr4:189140295-189140296	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs546734849	chr4:189140297-189140298	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs566688921	chr4:189140299-189140300	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs4241901	chr4:189140303-189140304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs138247825	chr4:189140305-189140306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs552529097	chr4:189140306-189140307	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs568857953	chr4:189140308-189140309	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs71642078	chr4:189140309-189140310	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
abnormal development	18461090	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16774939	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	17053054	CNVD
Facioscapulohumeral muscular dystrophy	21829175	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	20844748	CNVD
Autism	18414403	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164920	CNVD
Cancer	20164919	CNVD
Breast cancer	20409316	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Developmental delay	22127048	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Cervical cancer	21063398	CNVD
Cognitive impairment	21505072	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Tetralogy of Fallot	22912587	CNVD
Autism	20808228	CNVD
Epilepsy	21635232	CNVD
Schizophrenia	23813976	CNVD
Breast cancer	22522925	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:400 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:189137800-189140000	Enhancers	Fetal Brain Male	brain
2	chr4:189139200-189139800	Active TSS	H9 Cell Line	embryonic stem cell
3	chr4:189139200-189139800	Active TSS	iPS-20b Cell Line	embryonic stem cell
4	chr4:189139200-189140200	Active TSS	ES-I3 Cell Line	embryonic stem cell
5	chr4:189139200-189140200	Active TSS	iPS-15b Cell Line	embryonic stem cell
6	chr4:189139400-189139800	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr4:189139400-189139800	Active TSS	HUES64 Cell Line	embryonic stem cell
8	chr4:189139400-189139800	Active TSS	iPS-18 Cell Line	embryonic stem cell
9	chr4:189139400-189139800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
10	chr4:189139400-189139800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr4:189139400-189140000	Active TSS	H1 Cell Line	embryonic stem cell
12	chr4:189139400-189140000	Active TSS	HUES48 Cell Line	embryonic stem cell
13	chr4:189139400-189140000	Enhancers	Fetal Stomach	stomach
14	chr4:189139600-189139800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr4:189139600-189139800	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
16	chr4:189139600-189140000	Active TSS	HUES6 Cell Line	embryonic stem cell
17	chr4:189139600-189140200	Bivalent Enhancer	Placenta	Placenta
18	chr4:189139800-189140000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr4:189139800-189140000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
20	chr4:189139800-189140000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
21	chr4:189140000-189140200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr4:189140000-189141000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr4:189140200-189140400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
24	chr4:189140200-189141000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr4:189140200-189144200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
26	chr4:189140400-189141200	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr4:189140800-189141600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr4:189144400-189144800	Enhancers	Fetal Heart	heart
29	chr4:189147000-189147400	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr4:189152000-189152200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr4:189152600-189153000	ZNF genes & repeats	ES-UCSF4 Cell Line	embryonic stem cell
32	chr4:189152600-189153000	Active TSS	Breast Myoepithelial Primary Cells	Breast
33	chr4:189152800-189153000	ZNF genes & repeats	Fetal Kidney	kidney
34	chr4:189153000-189157400	Weak transcription	Fetal Kidney	kidney
35	chr4:189157600-189157800	Enhancers	Fetal Kidney	kidney
36	chr4:189166200-189167000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr4:189166400-189166800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr4:189168200-189169600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr4:189173600-189174000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr4:189174000-189175400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr4:189175400-189175600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr4:189181400-189183600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr4:189183200-189183800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr4:189183400-189184800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr4:189183400-189184800	Enhancers	Osteobl	bone
46	chr4:189183600-189183800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr4:189183600-189184000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr4:189183600-189184400	Enhancers	A549	lung
49	chr4:189183600-189184800	Enhancers	Hela-S3	cervix
50	chr4:189183800-189189600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links